Organogenesis Holdings Inc (NASDAQ: ORGO) is -5.38% lower on its value in year-to-date trading and has touched a low of $2.16 and a high of $4.70 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ORGO stock was last observed hovering at around $3.90 in the last trading session, with the day’s loss setting it -0.03%.
Currently trading at $3.87, the stock is 5.01% and 19.21% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.63 million and changing -0.77% at the moment leaves the stock 32.84% off its SMA200. ORGO registered 43.87% gain for a year compared to 6-month gain of 40.73%. The firm has a 50-day simple moving average (SMA 50) of $3.2449 and a 200-day simple moving average (SMA200) of $2.912825.
The stock witnessed a 33.91% loss in the last 1 month and extending the period to 3 months gives it a 34.37%, and is -3.73% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.19% over the week and 7.04% over the month.
Organogenesis Holdings Inc (ORGO) has around 862 employees, a market worth around $509.12M and $455.04M in sales. Fwd P/E is 125.53. Profit margin for the company is -1.62%. Distance from 52-week low is 78.75% and -17.75% from its 52-week high. The company has generated returns on investments over the last 12 months (-2.01%).
The EPS is expected to shrink by -174.65% this year.
Organogenesis Holdings Inc (ORGO) Top Institutional Holders
152.0 institutions hold shares in Organogenesis Holdings Inc (ORGO), with institutional investors hold 85.36% of the company’s shares. The shares outstanding are 131.32M, and float is at 71.36M with Short Float at 14.59%. Institutions hold 48.28% of the Float.
The top institutional shareholder in the company is MORGAN STANLEY with over 11.58 million shares valued at $32.41 million. The investor’s holdings represent 8.7789% of the ORGO Shares outstanding. As of 2024-06-30, the second largest holder is SOLEUS CAPITAL MANAGEMENT, L.P. with 11.52 million shares valued at $32.25 million to account for 8.7356 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 5.09 million shares representing 3.8579% and valued at over $14.24 million, while ASSENAGON ASSET MANAGEMENT S.A. holds 3.0161 of the shares totaling 3.98 million with a market value of $11.14 million.
Organogenesis Holdings Inc (ORGO) Insider Activity
The most recent transaction is an insider sale by ERANI ALBERT, the company’s 10% Owner. SEC filings show that ERANI ALBERT sold 197,921 shares of the company’s common stock on Jan 09 ’24 at a price of $4.37 per share for a total of $0.86 million. Following the sale, the insider now owns 59.03 million shares.
Organogenesis Holdings Inc disclosed in a document filed with the SEC on Jan 10 ’24 that ERANI ALBERT (10% Owner) sold a total of 17,972 shares of the company’s common stock. The trade occurred on Jan 10 ’24 and was made at $4.28 per share for $76875.0. Following the transaction, the insider now directly holds 59.01 million shares of the ORGO stock.
Still, SEC filings show that on Jan 09 ’24, ERANI ALBERT (10% Owner) disposed off 197,921 shares at an average price of $4.37 for $0.86 million. The insider now directly holds 59,025,106 shares of Organogenesis Holdings Inc (ORGO).
